Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bio to Cut Staff at Genomic Solutions UK Operations

NEW YORK, June 7 (GenomeWeb News) - Harvard Bioscience plans to eliminate certain jobs at the Huntingdon, UKfacility of its Genomic Solutions subsidiary, according to an 8-K filed with the US Securities and Exchange Commission.


In the filing, Harvard Bioscience said that it will reorganize, consolidate, and eliminate certain activities at the facility. Part of the reorganization includes relocating some activities to the firm's Holliston, Mass., facilities.


According to Harvard Bio, "this will result in the elimination of a number of employee positions."


The firm expects to take second-quarter charges of $600,000 to $800,000 related to severance and benefits and charges of $100,000 to $300,000 related to lease terminations.


Genomic Solutions is part of Harvard Bio's capital equipment business, which the firm last August said it plans to divest. At that time, Harvard Bio said it expected to complete the divestiture or sale within one year.


According to the most recent filing, Harvard Bio is continuing its efforts to divest the capital equipment business. The firm said it would kill the reorganization plan if it sells the business "prior to our completion of all activities under this plan."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.